These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17301295)

  • 21. Measuring the prevalence of Mycobacterium tuberculosis resistance is not that easy: the interest and limits of a retrospective survey.
    Chaulet P
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1077. PubMed ID: 11769763
    [No Abstract]   [Full Text] [Related]  

  • 22. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 23. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 24. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 26. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 27. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-resistant tuberculosis: World Health Organization launches global response plan 2007-2008.
    Euro Surveill; 2007 Jul; 12(7):E070705.3. PubMed ID: 17868565
    [No Abstract]   [Full Text] [Related]  

  • 29. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The global threat of drug-resistant tuberculosis.
    Snider DE; Castro KG
    N Engl J Med; 1998 Jun; 338(23):1689-90. PubMed ID: 9614262
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 33. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 34. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB?
    Edginton ME; Miller DL; Burney P; El Sony AI; Lwilla FI; O'Brien R; Roldan MB; Roldan A; Srinath S
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1094-6. PubMed ID: 20819252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-drug-resistant central nervous system tuberculosis.
    Murthy JM
    Neurol India; 2012; 60(2):143-5. PubMed ID: 22626692
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.
    Laniado-Laborín R
    Expert Rev Respir Med; 2010 Apr; 4(2):143-6. PubMed ID: 20406077
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tuberculosis as an international and national problem].
    Khomenko AG
    Probl Tuberk; 1994; (2):2-4. PubMed ID: 8036208
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in public health-- values, trust, and XDR-TB.
    Ratzan SC
    J Health Commun; 2007 Sep; 12(6):511-2. PubMed ID: 17763049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.